Tackling AMR requires a multi-faceted approach and research has shown how incorporating CRP (C-reactive protein) testing into clinical practice may help to limit antibiotic use to only those patients with severe bacterial infections and thereby support antimicrobial stewardship.
TORONTO (PRWEB) November 09, 2022
The World Antimicrobial Awareness Week, held from November 18 to 24, 2022, calls attention to the high priority global issue¹,² of antimicrobial resistance (AMR). We know that 80% of acute respiratory tract infections in general practice are caused by viral infection where the use of antibiotics is of little to no benefit³. There is a direct relationship between the prescribing of antimicrobials and the development of AMR4, making infections harder to treat and increasing the risk of disease spread, severe illness and death⁴. Tackling AMR requires a multi-faceted approach and research has shown how incorporating CRP (C-reactive protein) testing into clinical practice may help to limit antibiotic use to only those patients with severe bacterial infections and thereby support antimicrobial stewardship.
In this webinar, featured speaker Dr. Rogier Hopstaken, a GP from the Netherlands whose work and research drove the implementation of CRP point of care testing (POCT) in the country, will discuss how implementing CRP testing at the point of care has the potential to curb the problem of AMR and help change antibiotic prescribing behaviours in primary care settings. Rogier will review international experiences, barriers to implementation and provide recommendations for next steps. Together with David Barber, Advanced Practitioner LHCH Knowsley Community Respiratory Service, and featured speakers from LumiraDx, Medical Director Matt Fay, and Associate Director in Medical Affairs Lucy Lehane, they will review case studies and explore the value of portable CRP testing with patients in community settings using the LumiraDx Platform technology at the point of care.
Register for this webinar to learn about supporting antimicrobial stewardship using point of care CRP testing and changing antibiotic prescribing behaviours in primary care settings.
Join Dr. Rogier Hopstaken, MD, PhD, Star-shl Diagnostic Centres, Etten-Leur, Netherlands; Dr. Matthew Fay, GP Principal, Willows Medical Practice, Bradford; Lucy Lehane, Associate Director Medical Affairs, LumiraDx; and David Barber, Advanced Practitioner, LHCH Knowsley Community Respiratory Service, for the live webinar on Tuesday, November 22, 2022, at 8am EST (2pm CET/EU-Central).
For more information, or to register for this event, visit Supporting Antimicrobial Stewardship Using Point of Care CRP Testing.
1. World Health Organisation (WHO). Global action plan on antimicrobial resistance, 2015.
2. O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. London: HM Government and Wellcome Trust, 2016.
3. Goossens H, Ferech M, Vander Stichele R, et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet, 2005;365:579–87.
4. World Health Organisation (WHO). Antimicrobial Resistance Factsheet, November 2021.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Tel: +1 (416) 977-6555 x371